Urokinase Dosing for Dialysis Fistula Thrombosis
For local intra-access infusion in a thrombosed dialysis fistula, urokinase should be administered at 300,000 IU per session, which can be repeated up to three times if needed for successful thrombolysis 1.
Evidence-Based Dosing Recommendations
Primary Dosing Protocol
The most robust evidence for arteriovenous fistula (AVF) thrombolysis comes from a comparative study demonstrating that 300,000 IU of urokinase administered via local venous infusion achieved an 85.7% cumulative success rate after up to three treatment sessions 1. This approach proved superior to peripheral venous administration (68.4% success rate) and resulted in significantly fewer bleeding complications.
Alternative Dosing from Clinical Experience
Other research protocols have used variable dosing:
- 243,000 IU ± 100,000 IU for local thrombolytic infusion in conjunction with angiography, achieving immediate patency in 86% of cases 2
- Bolus administration techniques without specific dosing mentioned, though these focused on Brescia-Cimino fistulas specifically 3
Context: Catheter vs. Fistula Dosing
Important distinction: The KDOQI guidelines primarily address central venous catheter (CVC) dysfunction, where they reference 5,000 IU/mL of urokinase with a 40-minute dwell time 4. However, this is fundamentally different from treating a thrombosed fistula, which requires substantially higher doses for effective thrombolysis.
Administration Technique
- Route: Local venous infusion directly into the thrombosed access is superior to peripheral venous administration
- Frequency: Can repeat up to 3 sessions if initial thrombolysis is incomplete
- Timing: Earlier intervention (within 72 hours) yields significantly better results than subacute thrombosis (>72 hours), with success rates of 79.5% vs. 42.9% respectively 5
Clinical Factors Affecting Success
Protective factors for thrombolysis success include:
- Higher systolic blood pressure (OR=1.10)
- Higher diastolic blood pressure (OR=1.08)
Risk factors include:
- Older thrombus age (OR=0.91) 1
Safety Profile
Local infusion at 300,000 IU demonstrates favorable safety compared to peripheral administration:
- Less ecchymosis: 4.1% vs. 14.0%
- Less epistaxis: 2.0% vs. 10.5%
- Less gingival bleeding: 4.1% vs. 19.3% 1
Common Pitfall
Do not confuse catheter locking doses with fistula thrombolysis doses. Catheter maintenance uses 5,000-25,000 IU for prophylaxis 4, 6, while acute fistula thrombosis requires 300,000 IU for therapeutic effect. Using catheter-level dosing for fistula thrombosis will result in treatment failure.